Ozan Pamir - 19 Feb 2026 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Role
Chief Financial Officer
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Issuer symbol
NAGE
Transactions as of
19 Feb 2026
Net transactions value
$0
Form type
4
Filing time
24 Feb 2026, 16:46:19 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pamir Ozan Chief Financial Officer 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES /s/ Jeong James Lee, Attorney-in-Fact 24 Feb 2026 0001834681

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAGE Employee Stock Options (right to buy) Award $0 +62,131 $0.000000 62,131 19 Feb 2026 Common Stock 62,131 $4.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option shall vest on each anniversary of the grant date.